Understanding Patient Preference on Colorectal Cancer Screening Options-PSU
Launched by MILTON S. HERSHEY MEDICAL CENTER · May 30, 2024
Trial Information
Current as of February 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Understanding Patient Preference on Colorectal Cancer Screening Options," is focused on improving colorectal cancer (CRC) screening, especially for people who may have difficulty accessing traditional screening methods. The study is looking at whether offering a simple blood test for CRC screening—something that is less stressful and easier for patients—can help more people get screened. By making screening more accessible, the goal is to catch any potential issues early when treatment is most effective.
To participate in this trial, you need to be between 45 and 75 years old, speak English or Spanish, and be at average risk for colorectal cancer. You must also be a patient at one of the partnering health centers and have previously been offered a screening test (like a stool test or colonoscopy) but did not complete it. If you join the study, you will provide a blood sample, and this will help researchers understand if this new screening option can encourage more people to get tested. If you have a family history of certain cancers or other specific health conditions, you may not be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- To be enrolled in this study, participants must meet all the following criteria:
- • 1. Between 45-75 years of age
- • 2. Language Proficiency: participants must be fluent in English or Spanish
- • 3. Have an average risk for colorectal cancer
- • 4. Be a patient at one of our partner FQHCs
- • 5. Received a screening order (either using a stool-based test or colonoscopy) six months ago and failed or refused to complete the screening test
- • 6. Able and willing to provide a blood sample per protocol
- Exclusion Criteria:
- Participants will be excluded from enrolling in the study if they meet any of the following:
- • 1. Family history
- • One first-degree relative diagnosed with CRC or advanced adenoma at age \<60 years
- • Two first-degree relatives diagnosed with CRC or advanced adenoma at any age
- • Known hereditary gastrointestinal cancer syndromes, such as Lynch Syndrome or Familial Adenomatous and Polyposis (FAP)
- • 2. Personal History
- • Participants who do not speak either Spanish or English
- • History of CRC or adenoma
- • History of cancers
- • History of inflammatory bowel disease, including chronic ulcerative colitis and Crohn's disease
- • Have a recorded up to date CRC screening
- • Blood product transfusion in the past 120 days
- • A medical condition which, in the opinion of the patient's health provider, should preclude enrollment in the study
Trial Officials
Karen E. Kim, MD
Principal Investigator
Penn State College of Medicine
About Milton S. Hershey Medical Center
Milton S. Hershey Medical Center, a leading academic medical institution affiliated with Penn State University, is dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the center leverages its expertise in various medical fields to conduct rigorous clinical studies aimed at improving treatment outcomes and enhancing the understanding of complex health conditions. The facility is committed to ethical research practices and fostering collaboration among multidisciplinary teams, ensuring that participants receive the highest standard of care while contributing to the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hershey, Pennsylvania, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0